SGSoumaya Ghodbane

Soumaya Ghodbane

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Soumaya Ghodbane has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Marine biotoxins in seafood: A critical review of occurrence evidence, surveillance gaps and geographic expansion

    by Hadil Grami, Rym ElFessi, May Elfaieres, Soumaya Ghodbane, Riadh Kharrat, Rahma Ben Abderrazek, Riadh Marrouchi

  • Open Access

    Protective Effects of Bee Venom ( Apis mellifera ) Against Cadmium‐Induced Hepatorenal Toxicity, Oxidative Stress, and Anxiety‐Like Behavior in Rats

    by Soumaya Ghodbane, Chedli Ellijimi, Rym Elfessi, Ranya Hezzi, Khemaies Ben Rhouma, Hafedh Abdelmelek, Najet Srairi‐Abid, Mohsen Sakly, Riadh Marrouchi

    Cadmium (Cd) is a persistent environmental heavy metal and a major public health concern because it persists in the body for long periods and gradually accumulates in vital organs, particularly the liver, kidneys, and brain. Chronic Cd exposure promotes the excessive production of reactive oxygen species (ROS), which ultimately leads to oxidative stress, inflammatory responses, organ dysfunction, and neurobehavioral alterations. Apis mellifera bee venom (BV) consists of a diverse mixture of biologically active peptides, including key components such as melittin and apamin with documented antioxidant, anti‐inflammatory, and neuroprotective properties. However, to date, no studies have directly investigated its potential to mitigate Cd‐induced multi‐organ toxicity. Therefore, the present study aimed to evaluate the protective effects of BV against Cd‐induced hepatorenal injury, oxidative imbalance, and anxiety‐like behavior in a rat model, and to investigate its potential as a natural therapeutic strategy against heavy metal‐induced systemic toxicity. Male Wistar rats were assigned to control, BV (1 mg/kg/day, subcutaneous route), Cd (40 mg/L in drinking water), and Cd + BV for 14 days. Anxiety‐like behavior was investigated using two behavioral tests, namely the elevated plus maze (EPM) and the open field test (OFT), while hepatic and renal function markers and oxidative stress parameters were quantified in plasma and tissue samples. BV composition was verified by RP‐HPLC ESI‐MS analysis, confirming melittin as the predominant peptide component. Cd exposure induced anxiety‐like behavior, elevated plasma ALT, AST, and urea levels, increased lipid peroxidation, and reduced antioxidant enzyme activities in brain, liver, and kidney. Co‐administration of BV markedly attenuated these behavioral and biochemical alterations, reducing MDA levels and restoring SOD and CAT activities. Collectively, these findings highlight the potential of BV to protect against Cd‐induced hepatorenal and neurobehavioral toxicity, likely through modulation of oxidative stress pathways, thereby underscoring its promise as a natural therapeutic candidate for mitigating oxidative damage induced by heavy metals.

  • Open Access

    Phycocyanin Mitigates Subacute Alcohol-induced Hepatorenal Toxicity and Impaired Body Growth in Rats

    by Oumayma Boukari, Latifa Hajri, Thelja Laassili, Wahid Khemissi, Dorsaf Hallègue, Olfa Tebourbi, Khemais Ben Rhouma, Mohsen Sakly, Soumaya Ghodhbane

    Background: Alcohol consumption induces significant oxidative stress and inflammation, leading to damage in vital organs, particularly the liver and kidneys. Aim: Here, we investigate the potential therapeutic effects of phycocyanin in mitigating alcohol-induced liver and kidney damage and body growth. Methods: Four groups of male rats were included: control, ethanol-exposed (38% w/v, 1 ml/kg), phycocyanin co-treated (50 mg/kg phycocyanin followed by ethanol), and phycocyanin-only treated (50 mg/kg phycocyanin). Results: The results revealed that a 14-day exposure of rats to ethanol resulted in a decrease in body weight, with a significant increase in blood aspartate aminotransferase (ASAT) and alanine aminotransferase (ALAT) activity and elevated levels of urea, creatinine, iron, and C-reactive protein compared to the control group. However, co-treatment with phycocyanin significantly attenuated these effects, whereas phycocyanin alone did not induce significant effects. Additionally, ethanol exposure increased oxidative stress, lipid peroxidation and caused histopathological damage in both the liver and kidney. Co-treatment with phycocyanin significantly improved oxidative stress markers and preserved organ structure. Conclusion: These findings suggest that phycocyanin represents a promising natural therapeutic strategy for the prevention and management of alcohol-induced hepatorenal damage, calcium homeostasis alteration and impaired body growth. Major Finding: Phycocyanin exhibits notable antioxidant and anti-inflammatory properties, highlighting potential to improve organ health in cases of alcohol poisoning.